Jynarque
Ended Awarded
- Contract number
- 36C24622N0677
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $91,462
Award facts
- Contract value 100% obligated
- $91,461.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a delivery order award valued at $91,461.92 from the Department of Veterans Affairs Veterans Integrated Service Network 6 on May 8, 2022, for the supply of Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm-fixed price delivery order, with a completion date of July 31, 2022, was issued without a set-aside designation and is being fulfilled at the Pittsburgh, Pennsylvania location. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a General Services Administration contract vehicle that streamlines federal procurement of pharmaceutical products.
This delivery order is one of multiple task orders issued against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, which carries a ceiling value of $83.3 million through March 26, 2026. The BPA enables VA Integrated Service Networks across the country to efficiently procure Jynarque and supports the Veterans Health Administration's mission to provide specialized pharmaceutical treatments to veterans. Otsuka America Pharmaceutical Inc. is a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, and maintains additional federal supply schedule contracts totaling approximately $396 million, establishing its status as an established supplier of pharmaceutical and hematology-related products to federal healthcare systems.
Quick answers
Who was awarded contract 36C24622N0677?
36C24622N0677 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on May 8, 2022.
How much is contract 36C24622N0677 worth?
The government has obligated $91,462 on 36C24622N0677.
Is contract 36C24622N0677 an order under another contract?
Yes. 36C24622N0677 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0677 competed?
The extent of competition for 36C24622N0677 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award